tirzepatide versus semaglutide for weight loss vs. Semaglutide: Which is Best Loss? Tirzepatide vs Semaglutide: 2025 NEJM

Most patients tolerate long-term use well, especially with medical guidance

Engagement Algorithms: Platforms like TikTok and YouTube prioritize content that provokes intense curiosity or debate

Do not self-medicate with any of these compounds

Hold the needle at a 90-degree angle to your skin, and insert it between your 2 fingers

[DOI] [PubMed] [Google Scholar] [171].Ueno N, Fujiya M, Segawa S, Nata T, Moriichi K, Tanabe H, et al

Adults seeking the strongest available weight-loss outcome in a brand-name SKU Adults with obesity and moderate-to-severe OSA (cross-listed indication) Adults with pre-diabetes and obesity who want T2D progression prevention Clients who plateaued on a semaglutide SKU and want a tirzepatide trial Clients comfortable with weekly subcutaneous injection In SURMOUNT-5, a 72-week head-to-head trial sponsored by Eli Lilly, adults on Zepbound (tirzepatide) achieved 20.2% mean body weight loss, compared with 13.7% for adults on Wegovy (semaglutide)